Patent details

Basic Information

Publication number:

EP2440228

PCT Application Number:

US2010037855

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP107867301

PCT Publication Number:

WO2010144508

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLUCOSE-REGULATING POLYPEPTIDES AND METHODS OF MAKING AND USING SAME

French Title of Invention:

POLYPEPTIDES DE RÉGULATION DU GLUCOSE ET LEURS PROCÉDÉS DE PRODUCTION ET D'UTILISATION

German Title of Invention:

GLUCOSEREGULIERENDE POLYPEPTIDE SOWIE VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG

SPC Number:

Dates

Filing date:

08/06/2010

Grant date:

26/09/2018

EP Publication Date:

18/04/2012

PCT Publication Date:

16/12/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/09/2018

EP B1 Publication Date:

26/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/01/2023

 

 

Name:

AMUNIX PHARMACEUTICALS, INC

Address:

2 Tower Place, #1100 South San Francisco,, 94080, California, United States (US)

History of Owners

From:

19/09/2018

To:

18/01/2023

Name:

Amunix Operating Inc.

Address:

500 Ellis Street, Mountain View, CA 94043, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/11/2018

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

STEMMER, Willem, P.

Address:

United States (US)

2

Name:

SPINK, Benjamin

Address:

United States (US)

3

Name:

WANG, Chia-wei

Address:

United States (US)

4

Name:

SILVERMAN, Joshua

Address:

United States (US)

5

Name:

SCHELLENBERGER, Volker

Address:

United States (US)

6

Name:

GEETHING, Nathan

Address:

United States (US)

7

Name:

CLELAND, Jeffrey. L.

Address:

United States (US)

Priority

1

Priority Number:

268193 P

Priority Date:

08/06/2009

Priority Country:

United States (US)

2

Priority Number:

236836 P

Priority Date:

25/08/2009

Priority Country:

United States (US)

3

Priority Number:

28095509 P

Priority Date:

10/11/2009

Priority Country:

United States (US)

4

Priority Number:

699761

Priority Date:

03/02/2010

Priority Country:

United States (US)

5

Priority Number:

PCT/US2010/023106

Priority Date:

03/02/2010

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:

A61K 38/22; A61K 38/27; A61P 3/04; A61P 3/08; A61P 3/10; C07K 14/46; C07K 14/575; C07K 14/605; C07K 14/61; C12N 1/21; C12N 5/10; C12N 15/62; C12N 15/63;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/02

Publication date:

08/02/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201839

Publication date:

26/09/2018

Description:

Grant (B1)

2

Issue number:

202308

Publication date:

22/02/2023

Description:

Priority information

3

Issue number:

202308

Publication date:

22/02/2023

Description:

Document reprinted after correction (B8, B9)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000016A

Date Registered:

18/01/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Change of name and address

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

AMUNIX PHARMACEUTICALS, INC

Address:

2 Tower Place, #1100 South San Francisco,, 94080, California, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/05/2024

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
18/01/2023	Request For Change	1
18/01/2023	Outgoing Correspondence	1
07/11/2018	Power Of Attorney	1
29/11/2018	Outgoing Correspondence	1